1. Home
  2. BOTJ vs ALXO Comparison

BOTJ vs ALXO Comparison

Compare BOTJ & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank of the James Financial Group Inc.

BOTJ

Bank of the James Financial Group Inc.

HOLD

Current Price

$18.54

Market Cap

71.6M

Sector

Finance

ML Signal

HOLD

Logo ALX Oncology Holdings Inc.

ALXO

ALX Oncology Holdings Inc.

HOLD

Current Price

$1.42

Market Cap

79.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOTJ
ALXO
Founded
1998
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.6M
79.7M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BOTJ
ALXO
Price
$18.54
$1.42
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$3.30
AVG Volume (30 Days)
4.7K
194.6K
Earning Date
01-30-2026
11-07-2025
Dividend Yield
2.16%
N/A
EPS Growth
N/A
N/A
EPS
1.74
N/A
Revenue
$47,669,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$10.64
N/A
Revenue Growth
8.53
N/A
52 Week Low
$11.56
$0.40
52 Week High
$18.55
$2.27

Technical Indicators

Market Signals
Indicator
BOTJ
ALXO
Relative Strength Index (RSI) 65.90 49.15
Support Level $17.76 $1.29
Resistance Level $18.50 $1.57
Average True Range (ATR) 0.36 0.11
MACD 0.03 0.01
Stochastic Oscillator 99.37 55.00

Price Performance

Historical Comparison
BOTJ
ALXO

About BOTJ Bank of the James Financial Group Inc.

Bank of the James Financial Group Inc is a bank holding company that provides retail and commercial banking, deposit services, lending services, mortgage brokerage services, and other banking services. The company provides a range of deposit services including checking accounts, savings accounts and other time deposits of various types, ranging from daily money market accounts to longer-term certificates of deposit. It offers various types of secured and unsecured consumer loans, including personal loans, lines of credit, overdraft lines of credit, automobile loans, installment loans, demand loans, and home equity loans. It operates three business segments community banking; mortgage banking, and investment advisory services.

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Share on Social Networks: